78 These changes stabilize its structure, prevent protein degradation of the molecule in the circulation, and increase the circulation time enough to ensure once-daily injection (compared with exenatide, which is injected two or three times daily)
The bigger risk to absorption is not which site you pick
Clarification, April 1, 4:15 pm ET: A previous version of this post referred to the semaglutide revolution. The story has been updated to clarify that not all the medications for weight loss discussed are semaglutides.
In the 1990s, exendin-4, a GLP-1 receptor agonist (GLP-1 RA) structurally similar to endogenous GLP-1, was isolated from Gila monster venom, which subsequently led to the approval of exenatide for type 2 diabetes mellitus (T2DM) management in 2005 [2]
Overall, 36 percent of employers are providing GLP-1 coverage for both diabetes and weight loss (up from 34 percent in 2024)
If cost-effectiveness watchdogs are leaning in, it opens the door to broader payer support, value-based pricing negotiations, and increased global market momentum
